,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,ogalnac_site,oglcnac_site,disorder_propensity,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af
0,1,M,,,,,,,,,,,C,,,,,,,,,,,,
1,2,P,S,,,,,,,,,,C,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:87426037-87426037","hg19,16:g.87426037C>T",0.055,,,0.0000405975966223,
2,3,S,L,,,,,,,,,,C,,,COSMIC,,,"hg38,16:87392435-87392435","hg38,16:g.87392435C>T",0.227,"urinary_tract, bladder","carcinoma, small_cell_carcinoma",0.0012579161967554,
3,3,S,W,,,,,,,,,,C,,,COSMIC,,,"hg38,16:87392435-87392435","hg38,16:g.87392435C>G",0.158,oesophagus,"carcinoma, squamous_cell_carcinoma",0.0000216882102889,0.0000321957501610
4,4,E,,,,,,,,,,,C,,,,,,,,,,,,
5,5,K,,,,Ubq,,,,,,,C,"PCSK cleavage site, 5-9, ELM",,,,,,,,,,,
6,6,T,,P,,,,,,,,,C,"PCSK cleavage site, 5-9, ELM",,,,,,,,,,,
7,7,F,,,,,,,,,,,C,"PCSK cleavage site, 5-9, ELM",,,,,,,,,,,
8,8,K,,,,,,,,,,,S,"PCSK cleavage site, 5-9, ELM",,,,,,,,,,,
9,9,Q,,,,,,,,,,,S,"PCSK cleavage site, 5-9, ELM",,,,,,,,,,,
10,10,R,,,,,,,,,,,S,"NRD cleavage site, 10-12, ELM|14-3-3 binding phosphopeptide motif, 10-14, ELM",,,,,,,,,,,
11,11,R,L,,,,,,,,,,S,"NRD cleavage site, 10-12, ELM|14-3-3 binding phosphopeptide motif, 10-14, ELM",,cBioPortal,lusc_cptac_2021,Lung Squamous Cell Carcinoma,"hg19,16:87426065-87426066",,,,,,
12,12,T,,,,,,,,,,,S,"NRD cleavage site, 10-12, ELM|14-3-3 binding phosphopeptide motif, 10-14, ELM",,,,,,,,,,,
13,13,F,,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 10-14, ELM",,,,,,,,,,,
14,14,E,,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 10-14, ELM",,,,,,,,,,,
15,15,Q,,,,,,,,,,,S,,,,,,,,,,,,
16,16,R,G,,,,,,,,,,S,,,COSMIC,,,"hg38,16:87398820-87398820","hg38,16:g.87398820A>G",0.762,oesophagus,"carcinoma, squamous_cell_carcinoma",,
17,17,V,,,,,,,,,,,S,,,,,,,,,,,,
18,18,E,,,,,,,,,,,S,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 18-23, ELM",,,,,,,,,,,
19,19,D,Y,,,,,,,,,,S,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 18-23, ELM",,cBioPortal,mixed_pipseq_2017,Mixed Cancer Types,"hg19,16:87432435-87432435","hg19,16:g.87432435G>T",0.524,,,,
20,20,V,,,,,,,,,,,S,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 18-23, ELM",,,,,,,,,,,
21,21,R,G,,Me,,,,,,,,S,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 18-23, ELM",,cBioPortal,skcm_tcga,Cutaneous Melanoma,"hg19,16:87432441-87432441","hg19,16:g.87432441C>G",0.125,,,,
22,21,R,Q,,Me,,,,,,,,S,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 18-23, ELM",,"cBioPortal,COSMIC","coad_cptac_2019, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_jhu_2014","Colon Adenocarcinoma, Endometrial Carcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,16:87432442-87432442, hg38,16:87398836-87398836","hg19,16:g.87432442G>A, hg38,16:g.87398836G>A",0.066,endometrium,"carcinoma, endometrioid_carcinoma",0.0000079526657336,
23,22,L,,,,,,,,,,,S,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 18-23, ELM",,,,,,,,,,,
24,23,I,F,,,,,,,,,,S,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 18-23, ELM",,cBioPortal,nsclc_mskcc_2018,Non-Small Cell Lung Cancer,"hg19,16:87432447-87432447","hg19,16:g.87432447A>T",0.632,,,,
25,24,R,,,,,,,,,,,S,,,,,,,,,,,,
26,25,E,Q,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
27,26,Q,,,,,,,,,,,S,,,,,,,,,,,,
28,27,H,,,,,,,,,,,S,,,,,,,,,,,,
29,28,P,L,,,,,,,,,,S,,,"cBioPortal,COSMIC","skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,16:87432463-87432463, hg38,16:87398857-87398857","hg19,16:g.87432463C>T, hg38,16:g.87398857C>T",0.411,skin,malignant_melanoma,,
30,29,T,A,P,,,,,,,,,S,,,"cBioPortal,COSMIC",gbc_shanghai_2014,Gallbladder Cancer,"hg19,16:87432465-87432465, hg38,16:87398859-87398859","hg19,16:g.87432465A>G, hg38,16:g.87398859A>G",0.147,"biliary_tract, gallbladder","carcinoma, adenocarcinoma",,0.0000955170657157
31,30,K,,,,Ubq,,,,,,,S,,,,,,,,,,,,
32,31,I,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 31-36, ELM|SUMO interaction site, 31-36, ELM",,,,,,,,,,,
33,32,P,L,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 31-36, ELM|SUMO interaction site, 31-36, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,16:87432474-87432475, hg38,16:87398868-87398869","hg19,16:g.87432474_87432475delinsTT, hg38,16:g.87398868_87398869delinsTT",,skin,"carcinoma, basal_cell_carcinoma",,
34,32,P,Q,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 31-36, ELM|SUMO interaction site, 31-36, ELM",,cBioPortal,lusc_tcga_pub,Lung Squamous Cell Carcinoma,"hg19,16:87432475-87432475","hg19,16:g.87432475C>A",0.755,,,,
35,32,P,S,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 31-36, ELM|SUMO interaction site, 31-36, ELM",,COSMIC,,,"hg38,16:87398868-87398868","hg38,16:g.87398868C>T",0.812,large_intestine,"carcinoma, adenocarcinoma",,
36,33,V,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 31-36, ELM|SUMO interaction site, 31-36, ELM",,,,,,,,,,,
37,34,I,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 31-36, ELM|SUMO interaction site, 31-36, ELM",,,,,,,,,,,
38,35,I,V,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 31-36, ELM|SUMO interaction site, 31-36, ELM",,cBioPortal,mm_broad,Plasma Cell Myeloma,"hg19,16:87435787-87435787","hg19,16:g.87435787A>G",0.284,,,,
39,36,E,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 31-36, ELM|SUMO interaction site, 31-36, ELM",,,,,,,,,,,
40,37,R,Q,,,,,,,,,,S,"MAPK docking motifs, 37-46, ELM",,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,16:87435794-87435794, hg38,16:87402188-87402188","hg19,16:g.87435794G>A, hg38,16:g.87402188G>A",0.514,lung,"carcinoma, adenocarcinoma",0.0000039783893888,
41,38,Y,H,,,,,,,,,,S,"MAPK docking motifs, 37-46, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,16:87435796-87435796, hg38,16:87402190-87402190","hg19,16:g.87435796T>C, hg38,16:g.87402190T>C",0.363,endometrium,"carcinoma, endometrioid_carcinoma",0.0000039770919504,
42,39,K,R,,,,,,,,,,S,"MAPK docking motifs, 37-46, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,16:87435800-87435800, hg38,16:87402194-87402194","hg19,16:g.87435800A>G, hg38,16:g.87402194A>G",0.065,"large_intestine, caecum","carcinoma, adenocarcinoma",,
43,40,G,,,,,,,,,,,C,"MAPK docking motifs, 37-46, ELM",,,,,,,,,,,
44,41,E,,,,,,,,,,,S,"MAPK docking motifs, 37-46, ELM",,,,,,,,,,,
45,42,K,,,,Ubq,,,,,,,C,"MAPK docking motifs, 37-46, ELM",,,,,,,,,,,
46,43,Q,,,,,,,,,,,S,"MAPK docking motifs, 37-46, ELM",,,,,,,,,,,
47,44,L,,,,,,,,,,,S,"MAPK docking motifs, 37-46, ELM",,,,,,,,,,,
48,45,P,,,,,,,,,,,S,"MAPK docking motifs, 37-46, ELM",,,,,,,,,,,
49,46,V,,,,,,,,,,,S,"MAPK docking motifs, 37-46, ELM",,,,,,,,,,,
50,47,L,,,,,,,,,,,S,,,,,,,,,,,,
51,48,D,,,,,,,,,,,S,"FHA phosphopeptide ligands, 48-54, ELM",,,,,,,,,,,
52,49,K,N,,,Ubq,,,,,,,S,"FHA phosphopeptide ligands, 48-54, ELM",,cBioPortal,"mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:87435831-87435831","hg19,16:g.87435831A>C",0.495,,,,
53,50,T,,P,,,,,,,,,S,"FHA phosphopeptide ligands, 48-54, ELM",,,,,,,,,,,
54,51,K,,,,Ubq,,,,,,,S,"FHA phosphopeptide ligands, 48-54, ELM",,,,,,,,,,,
55,52,F,,,,,,,,,,,S,"PP4 EVH1-binding docking motifs, 52-55, ELM|FHA phosphopeptide ligands, 48-54, ELM",,,,,,,,,,,
56,53,L,,,,,,,,,,,S,"PP4 EVH1-binding docking motifs, 52-55, ELM|FHA phosphopeptide ligands, 48-54, ELM",,,,,,,,,,,
57,54,V,,,,,,,,,,,S,"PP4 EVH1-binding docking motifs, 52-55, ELM|FHA phosphopeptide ligands, 48-54, ELM",,,,,,,,,,,
58,55,P,,,,,,,,,,,S,"PP4 EVH1-binding docking motifs, 52-55, ELM",,,,,,,,,,,
59,56,D,N,,,,,,,,,,S,,,"cBioPortal,COSMIC","prad_fhcrc, prad_p1000, stad_tcga, stad_tcga_pan_can_atlas_2018, stes_tcga_pub","Esophagogastric Adenocarcinoma, Prostate Adenocarcinoma, Stomach Adenocarcinoma","hg19,16:87435850-87435850, hg38,16:87402244-87402244","hg19,16:g.87435850G>A, hg38,16:g.87402244G>A",0.341,"prostate, stomach","carcinoma, adenocarcinoma",,
60,57,H,,,,,,,,,,,S,,,,,,,,,,,,
61,58,V,,,,,,,,,,,S,,,,,,,,,,,,
62,59,N,,,,,,,,,,,S,,,,,,,,,,,,
63,60,M,I,,,,,,,,,,S,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,16:87435864-87435864, hg38,16:87402258-87402258","hg19,16:g.87435864G>A, hg38,16:g.87402258G>A",0.261,"urinary_tract, bladder",carcinoma,,
64,60,M,V,,,,,,,,,,S,,,COSMIC,,,"hg38,16:87402256-87402256","hg38,16:g.87402256A>G",0.277,liver,carcinoma,0.0000994502390784,0.0004138545778683
65,61,S,,,,,,,,,,,S,,,,,,,,,,,,
66,62,E,,,,,,,,,,,S,"NES Nuclear Export Signal, 62-77, ELM",,,,,,,,,,,
67,63,L,F,,,,,,,,,,S,"NES Nuclear Export Signal, 62-77, ELM",,COSMIC,,,"hg38,16:87402265-87402265","hg38,16:g.87402265C>T",0.293,"skin, head_neck","malignant_melanoma, nodular",,
68,64,I,,,,,,,,,,,S,"NES Nuclear Export Signal, 62-77, ELM",,,,,,,,,,,
69,65,K,E,,,Ubq,,,,,,,S,"MAPK docking motifs, 65-73, ELM|NES Nuclear Export Signal, 62-77, ELM",,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,16:87435877-87435877, hg38,16:87402271-87402271","hg19,16:g.87435877A>G, hg38,16:g.87402271A>G",0.314,"large_intestine, colon","carcinoma, adenocarcinoma",0.0000278640235650,
70,66,I,,,,,,,,,,,S,"MAPK docking motifs, 65-73, ELM|NES Nuclear Export Signal, 62-77, ELM",,,,,,,,,,,
71,67,I,,,,,,,,,,,S,"MAPK docking motifs, 65-73, ELM|di Arginine retention/retrieving signal, 67-70, ELM|NES Nuclear Export Signal, 62-77, ELM",,,,,,,,,,,
72,68,R,,,,,,,,,,,S,"MAPK docking motifs, 65-73, ELM|di Arginine retention/retrieving signal, 67-70, ELM|di Arginine retention/retrieving signal, 68-70, ELM|NES Nuclear Export Signal, 62-77, ELM",,,,,,,,,,,
73,69,R,,,,,,,,,,,S,"NRD cleavage site, 69-71, ELM|MAPK docking motifs, 65-73, ELM|di Arginine retention/retrieving signal, 67-70, ELM|di Arginine retention/retrieving signal, 68-70, ELM|di Arginine retention/retrieving signal, 69-71, ELM|NES Nuclear Export Signal, 62-77, ELM",,,,,,,,,,,
74,70,R,C,,,,,,,,,,S,"NRD cleavage site, 69-71, ELM|MAPK docking motifs, 65-73, ELM|di Arginine retention/retrieving signal, 67-70, ELM|di Arginine retention/retrieving signal, 68-70, ELM|di Arginine retention/retrieving signal, 69-71, ELM|NES Nuclear Export Signal, 62-77, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:87436533-87436533, hg38,16:87402927-87402927","hg19,16:g.87436533C>T, hg38,16:g.87402927C>T",0.467,endometrium,"carcinoma, endometrioid_carcinoma",,
75,70,R,H,,,,,,,,,,S,"NRD cleavage site, 69-71, ELM|MAPK docking motifs, 65-73, ELM|di Arginine retention/retrieving signal, 67-70, ELM|di Arginine retention/retrieving signal, 68-70, ELM|di Arginine retention/retrieving signal, 69-71, ELM|NES Nuclear Export Signal, 62-77, ELM",,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,16:87436534-87436534, hg38,16:87402928-87402928","hg19,16:g.87436534G>A, hg38,16:g.87402928G>A",0.513,"upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, nasopharyngeal_carcinoma",0.0000079738457858,
76,71,L,,,,,,,,,,,S,"NRD cleavage site, 69-71, ELM|MAPK docking motifs, 65-73, ELM|di Arginine retention/retrieving signal, 69-71, ELM|NES Nuclear Export Signal, 62-77, ELM",,,,,,,,,,,
77,72,Q,,,,,,,,,,,S,"MAPK docking motifs, 65-73, ELM|NES Nuclear Export Signal, 62-77, ELM",,,,,,,,,,,
78,73,L,,,,,,,,,,,S,"MAPK docking motifs, 65-73, ELM|NES Nuclear Export Signal, 62-77, ELM",,,,,,,,,,,
79,74,N,S,,,,,,,,,,C,"NES Nuclear Export Signal, 62-77, ELM",,cBioPortal,gbm_mayo_pdx_sarkaria_2019,Glioblastoma Multiforme,"hg19,16:87436546-87436546","hg19,16:g.87436546A>G",0.145,,,0.0000796400270776,0.0000318410494810
80,75,A,D,,,,,,,,,,C,"NES Nuclear Export Signal, 62-77, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:87436549-87436549","hg19,16:g.87436549C>A",0.206,,,,
81,76,N,,,,,,,,,,,C,"NES Nuclear Export Signal, 62-77, ELM",,,,,,,,,,,
82,77,Q,,,,,,,,,,,C,"NES Nuclear Export Signal, 62-77, ELM",,,,,,,,,,,
83,78,A,,,,,,,,,,,S,,,,,,,,,,,,
84,79,F,,,,,,,,,,,S,,,,,,,,,,,,
85,80,F,,,,,,,,,,,S,,,,,,,,,,,,
86,81,L,,,,,,,,,,,S,,,,,,,,,,,,
87,82,L,F,,,,,,,,,,S,,,COSMIC,,,"hg38,16:87402965-87402965","hg38,16:g.87402965G>T",0.295,liver,"other, neoplasm",,
88,83,V,,,,,,,,,,,S,,,,,,,,,,,,
89,84,N,,,,,,,,,,,S,,,,,,,,,,,,
90,85,G,,,,,,,,,,,S,,,,,,,,,,,,
91,86,H,,,,,,,,,,,S,,,,,,,,,,,,
92,87,S,,,,,,,,,,,S,"SUMO interaction site, 87-93, ELM",,,,,,,,,,,
93,88,M,,,,,,,,,,,C,"SH3 ligand, 88-94, ELM|SUMO interaction site, 87-93, ELM",,,,,,,,,,,
94,89,V,F,,,,,,,,,,C,"SH3 ligand, 88-94, ELM|SUMO interaction site, 87-93, ELM",,"cBioPortal,COSMIC","lusc_tcga, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,16:87436590-87436590, hg38,16:87402984-87402984","hg19,16:g.87436590G>T, hg38,16:g.87402984G>T",0.578,lung,"carcinoma, squamous_cell_carcinoma",,
95,90,S,,,,,,,,,,,C,"WW domain ligands, 90-95, ELM|SH3 ligand, 88-94, ELM|SUMO interaction site, 87-93, ELM",,,,,,,,,,,
96,91,V,I,,,,,,,,,,S,"SCF ubiquitin ligase binding Phosphodegrons, 91-97, ELM|Cks1 ligand, 91-96, ELM|WW domain ligands, 90-95, ELM|SH3 ligand, 88-94, ELM|SUMO interaction site, 87-93, ELM",,COSMIC,,,"hg38,16:87402990-87402990","hg38,16:g.87402990G>A",0.172,endometrium,"carcinoma, endometrioid_carcinoma",0.0000875329243159,0.0000636942675159
97,92,S,,,,,,,,,,,S,"SCF ubiquitin ligase binding Phosphodegrons, 91-97, ELM|Cks1 ligand, 91-96, ELM|WW domain ligands, 90-95, ELM|SH3 ligand, 88-94, ELM|SUMO interaction site, 87-93, ELM",,,,,,,,,,,
98,93,T,,,,,,,,,,,S,"SCF ubiquitin ligase binding Phosphodegrons, 91-97, ELM|Cks1 ligand, 91-96, ELM|WW domain ligands, 90-95, ELM|SH3 ligand, 88-94, ELM|SUMO interaction site, 87-93, ELM",,,,,,,,,,,
99,94,P,,,,,,,,,,,S,"SCF ubiquitin ligase binding Phosphodegrons, 91-97, ELM|Cks1 ligand, 91-96, ELM|WW domain ligands, 90-95, ELM|SH3 ligand, 88-94, ELM",,,,,,,,,,,
100,95,I,,,,,,,,,,,S,"SCF ubiquitin ligase binding Phosphodegrons, 91-97, ELM|Cks1 ligand, 91-96, ELM|WW domain ligands, 90-95, ELM",,,,,,,,,,,
101,96,S,,,,,,,,,,,S,"SCF ubiquitin ligase binding Phosphodegrons, 91-97, ELM|Cks1 ligand, 91-96, ELM",,,,,,,,,,,
102,97,E,,,,,,,,,,,S,"SCF ubiquitin ligase binding Phosphodegrons, 91-97, ELM",,,,,,,,,,,
103,98,V,A,,,,,,,,,,S,,,cBioPortal,lihc_amc_prv,Hepatocellular Carcinoma,"hg19,16:87436618-87436618","hg19,16:g.87436618T>C",0.265,,,0.0000000000000000,
104,99,Y,,,,,,,,,,,S,,,,,,,,,,,,
105,100,E,,,,,,,,,,,S,,,,,,,,,,,,
106,101,S,,,,,,,,,,,S,,,,,,,,,,,,
107,102,E,,,,,,,,,,,S,,,,,,,,,,,,
108,103,K,,,,,,,,,,,S,,,,,,,,,,,,
109,104,D,H,,,,,,,,,,S,,,cBioPortal,lung_smc_2016,Lung,"hg19,16:87436635-87436635","hg19,16:g.87436635G>C",0.654,,,,
110,105,E,K,,,,,,,,,,S,"Atg8 protein family ligands, 105-114, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:87436638-87436638","hg19,16:g.87436638G>A",0.220,,,,
111,106,D,G,,,,,,,,,,S,"Atg8 protein family ligands, 105-114, ELM|Atg8 protein family ligands, 106-114, ELM",,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,16:87436642-87436642","hg19,16:g.87436642A>G",0.866,,,0.0000278396436526,
112,107,G,,,,,,,,,,,S,"Atg8 protein family ligands, 105-114, ELM|Atg8 protein family ligands, 106-114, ELM",,,,,,,,,,,
113,108,F,,,,,,,,,,,S,"Atg8 protein family ligands, 105-114, ELM|Atg8 protein family ligands, 106-114, ELM",,,,,,,,,,,
114,109,L,,,,,,,,,,,S,"Atg8 protein family ligands, 105-114, ELM|Atg8 protein family ligands, 106-114, ELM",,,,,,,,,,,
115,110,Y,,,,,,,,,,,S,"Atg8 protein family ligands, 105-114, ELM|Atg8 protein family ligands, 106-114, ELM",,,,,,,,,,,
116,111,M,V,,,,,,,,,,S,"Atg8 protein family ligands, 105-114, ELM|Atg8 protein family ligands, 106-114, ELM",,cBioPortal,"ccle_broad_2019, coad_cptac_2019","Colon Adenocarcinoma, Mixed Cancer Types","hg19,16:87436656-87436656","hg19,16:g.87436656A>G",0.274,,,0.0000039771235851,
117,112,V,,,,,,,,,,,S,"Atg8 protein family ligands, 105-114, ELM|Atg8 protein family ligands, 106-114, ELM",,,,,,,,,,,
118,113,Y,C,,,,,,,,,,S,"Atg8 protein family ligands, 105-114, ELM|Atg8 protein family ligands, 106-114, ELM|Phosphotyrosine ligands bound by SH2 domains, 113-116, ELM",,"cBioPortal,COSMIC","acbc_mskcc_2015, acc_2019, bcc_unige_2016, kich_tcga","Adenoid Cystic Breast Cancer, Adrenocortical Carcinoma, Basal Cell Carcinoma, Chromophobe Renal Cell Carcinoma","hg19,16:87436663-87436663, hg38,16:87403057-87403057","hg19,16:g.87436663A>G, hg38,16:g.87403057A>G",0.771,"breast, liver, oesophagus, middle_third, prostate, skin, skin, face, skin, foot","carcinoma, carcinoma, adenocarcinoma, carcinoma, adenoid_cystic_carcinoma, carcinoma, basal_cell_carcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma",0.0012870707888934,
119,114,A,T,,,,,,,,,,S,"Atg8 protein family ligands, 105-114, ELM|Atg8 protein family ligands, 106-114, ELM|Phosphotyrosine ligands bound by SH2 domains, 113-116, ELM|TRAF2 binding site, 114-117, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:87436665-87436665","hg19,16:g.87436665G>A",0.411,,,,
120,115,S,F,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 113-116, ELM|TRAF2 binding site, 114-117, ELM",,cBioPortal,cscc_ucsf_2021,Cutaneous Squamous Cell Carcinoma,"hg19,16:87436669-87436670","hg19,16:g.87436669_87436670delinsTT",,,,,
121,116,Q,,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 113-116, ELM|TRAF2 binding site, 114-117, ELM",,,,,,,,,,,
122,117,E,V,,,,,,,,,,C,"TRAF2 binding site, 114-117, ELM",,COSMIC,,,"hg38,16:87403069-87403069","hg38,16:g.87403069A>T",0.640,lung,"carcinoma, adenocarcinoma",0.0000000000000000,
123,118,T,A,,,,,,,,,,C,,,cBioPortal,pptc_2019,Mixed Cancer Types,"hg19,16:87436677-87436677","hg19,16:g.87436677A>G",0.435,,,0.0006486451424587,
124,119,F,,,,,,,,,,,C,,,,,,,,,,,,
125,120,G,R,,,,,,,,,,C,"PDZ domain ligands, 120-125, ELM",,"cBioPortal,COSMIC",stad_utokyo,Stomach Adenocarcinoma,"hg19,16:87436683-87436683, hg38,16:87403077-87403077","hg19,16:g.87436683G>A, hg38,16:g.87403077G>A",0.705,stomach,"carcinoma, carcinoma, diffuse_adenocarcinoma",0.0000040617714198,0.0000318511912346
126,120,G,V,,,,,,,,,,C,"PDZ domain ligands, 120-125, ELM",,COSMIC,,,"hg38,16:87403078-87403078","hg38,16:g.87403078G>T",0.678,liver,"other, neoplasm",,
127,121,M,,,,,,,,,,,C,"PDZ domain ligands, 120-125, ELM",,,,,,,,,,,
128,122,K,,,,,,,,,,,C,"PDZ domain ligands, 120-125, ELM",,,,,,,,,,,
129,123,L,S,,,,,,,,,,C,"PDZ domain ligands, 120-125, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,16:87436693-87436693, hg38,16:87403087-87403087","hg19,16:g.87436693T>C, hg38,16:g.87403087T>C",0.044,large_intestine,"carcinoma, adenocarcinoma",,
130,123,L,V,,,,,,,,,,C,"PDZ domain ligands, 120-125, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:87436692-87436692","hg19,16:g.87436692T>G",0.025,,,,
131,124,S,,,,,,,,,,,C,"PDZ domain ligands, 120-125, ELM",,,,,,,,,,,
132,125,V,A,,,,,,,,,,D,"PDZ domain ligands, 120-125, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:87436699-87436699","hg19,16:g.87436699T>C",0.035,,,0.0000393528640140,0.0000637429882713
